RxSight (RXST) Operating Expenses (2020 - 2026)

RxSight (RXST) has reported Operating Expenses for 7 consecutive years, with $47.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses changed 0.27% year-over-year to $47.5 million; the trailing twelve-month figure through Jun 2026 stood at $161.8 million (up 2.11% YoY), and the FY2025 full-year result was $151.2 million, up 11.34% from the prior year.
• Operating Expenses rose to $47.5 million in Q2 2026 per RXST's latest filing, from $41.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $47.6 million in Q2 2025 and bottomed at $20.3 million in Q1 2022.
• Historically, Operating Expenses has averaged $31.8 million across 5 years, with a median of $32.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses soared 65.98% in 2022, then retreated 2.18% in 2025.
• Over 5 years, Operating Expenses stood at $22.4 million in 2022, then rose by 27.19% to $28.5 million in 2023, then surged by 31.26% to $37.4 million in 2024, then fell by 2.18% to $36.6 million in 2025, then grew by 29.81% to $47.5 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $47.5 million, $41.3 million, and $36.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.